Compare Repligen Corporation Common Stock (RGEN) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Advanced Drainage Systems Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Advanced Drainage Systems Inc trades at $125.03 (market cap $9.56B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Advanced Drainage Systems Inc pays a 0.63% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Advanced Drainage Systems Inc for 43 Days on average.
| RGEN | WMS | |
|---|---|---|
Market Cap | $11.14B | $9.56B |
Volume | 1,259,263 | 716,757 |
Sector | Health | Basic Materials |
52-Week High | $194.57 | $175.38 |
52-Week Low | $102.87 | $125.19 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $11.02B | $11.16B |
Dividend Yield | — | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Advanced Drainage Systems (WMS) trades at $125.19, down 0.59% on the day, with technical indicators showing a bearish trend. The company maintains strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $2.49 beating estimates of $2.10. Revenue remains stable at $2.90B for 2025, while profitability metrics show robust ROE of 24.9% and net margin of 14%. Recent news highlights institutional buying activity and the release of Q1 2027 results showing 21% revenue growth.
WMS presents a compelling investment case with strong fundamentals and analyst consensus pointing to significant upside potential (target $188.20). However, near-term technical weakness and projected negative cash flow in 2026 warrant caution. The stock offers exposure to water infrastructure growth but faces execution risks from recent acquisitions and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
